Empagliflozin and Metformin Extended-Release Tablets and Larotrectinib Capsules
Determining the interaction of Empagliflozin and Metformin Extended-Release Tablets and Larotrectinib Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: empagliflozin / metformin
Brand name: Synjardy, Synjardy XR
Synonyms: Empagliflozin and metformin, Empagliflozin and Metformin
Generic Name: larotrectinib
Brand name: Vitrakvi
Synonyms: Larotrectinib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Empagliflozin and Metformin Extended-Release Tablets-Larotrectinib Oral Solution
- Empagliflozin and Metformin Extended-Release Tablets-Larotrectinib Sulfate
- Empagliflozin and Metformin Extended-Release Tablets-Lartruvo
- Empagliflozin and Metformin Extended-Release Tablets-Larynex
- Empagliflozin and Metformin Extended-Release Tablets-Laryng-O-Jet
- Empagliflozin and Metformin Extended-Release Tablets-Laryngesic
- Larotrectinib Capsules-Empagliflozin and Metformin Tablets
- Larotrectinib Capsules-Empliciti
- Larotrectinib Capsules-Emsam
- Larotrectinib Capsules-Emsam Transdermal
- Larotrectinib Capsules-Emtricitabine
- Larotrectinib Capsules-Emtricitabine and tenofovir